We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Four groups have sued the FDA to overturn a decision allowing OTC distribution of the contraceptive Plan B, saying the move was motivated by political pressure.
As part of a Senate Finance Committee investigation, Sen. Chuck Grassley (R-Iowa) is requesting information from Eli Lilly regarding the marketing of its antipsychotic drug Zyprexa.
One of two plaintiffs in a Vioxx product liability case can no longer seek compensatory or punitive damages against Merck following a two-pronged jury verdict.
Wyeth affirmed its strong financial forecast for 2007, although the company faces challenges from a prolonged FDA facility inspection, new generic competitors and litigation over its hormone-replacement therapies.
The indemnification clause in any clinical trial contract should be worded carefully so that both the sponsor and the sites are protected, J. Michael Slocum, president of law firm Slocum & Boddie, said at a recent FDAnews audioconference.
Eli Lilly won a federal court injunction Feb. 13 requiring the return of documents on its marketing practices for Zyprexa, an antipsychotic drug used to treat bipolar disorder and schizophrenia.
The judge overseeing the Center for Reproductive Rights’ (CRR) lawsuit against the FDA granted the center’s request for discovery of additional agency documents, but put a stay on documents the group sought from the White House.